- Home
- Pangobatan & Tata cara
- Endoskopi Kapsul - Biaya, Indikasi...
Deflazacort: Panganggone, dosis, efek sisih lan liyane
Pambuka: Apa Deflazacort?
If you or a loved one are managing an autoimmune disease, inflammatory disorder, or a specific type of cancer, your doctor may have prescribed Deflazacort. This corticosteroid medication is primarily used to reduce inflammation and suppress the immune system.
It is similar to other corticosteroids but is known for a lower risk of certain side effects, particularly bone mineral density loss and weight gain, making it a valuable option for various conditions, including Duchenne muscular dystrophy.
Indikasi lan panggunaan
FDA-Approved Indication
Deflazacort (brand name: Emflaza) is FDA-approved for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
DMD is a rare, inherited muscle disease characterised by progressive muscle degeneration and weakness, caused by an absence of the protein dystrophin.
Deflazacort is the only corticosteroid with a specific FDA approval for DMD.
Off-Label Use in India
In Indian clinical practice, deflazacort is widely prescribed off-label as a corticosteroid for various inflammatory and autoimmune conditions. These uses are based on clinical experience and regional prescribing patterns; they are not FDA-approved indications.
Common off-label uses include:
- Kelainan autoimun: Rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune hepatitis
- Kondisi inflamasi: Asthma, inflammatory bowel disease (IBD), nephrotic syndrome
- Kondisi alergi: Severe allergic reactions, allergic rhinitis (in moderate to severe cases only)
- Dermatological conditions: Severe eczema, pemphigus, and other autoimmune skin disorders
- Transplantasi organ: As part of immunosuppressive regimens to prevent graft rejection
- Kanker tartamtu: As part of treatment regimens for specific haematological malignancies, including leukaemia and lymphoma
Deflazacort is not recommended for mild allergies or conditions that can be managed with non-steroidal anti-inflammatory drugs. It should be used only when the clinical situation warrants corticosteroid therapy, as determined by the prescribing physician.
Cara kerjane
Deflazacort works by mimicking the effects of hormones produced by the adrenal glands, particularly cortisol.
Iki nyuda inflamasi kanthi nyegah pelepasan zat ing awak sing nyebabake inflamasi lan respon imun.
Kanthi tembung sing luwih prasaja, iki nenangake sistem kekebalan awak lan nyuda pembengkakan, abang, lan nyeri sing ana gandhengane karo macem-macem kondisi.
After oral administration, deflazacort is rapidly converted to its active metabolite, 21-desacetyldeflazacort, which is responsible for its therapeutic effects.
Dosis
DMD Dosing (FDA-Approved)
- Adults and children aged 2 years and older: 0.9 mg/kg/day, administered once daily
- Available formulations: Tablets (6 mg, 18 mg, 30 mg, 36 mg) and oral suspension (22.75 mg/mL)
- If using tablets, round up to the nearest possible dose; any combination of tablet strengths may be used to achieve the calculated dose
- If using oral suspension, round up to the nearest tenth of a millilitre (mL)
Off-Label Dosing (India)
For off-label inflammatory and autoimmune indications, the typical adult dose ranges from 6 to 48 mg/day, depending on the condition, severity, and clinical response.
The dose is usually started at a higher level and tapered gradually to the lowest effective maintenance dose.
Dosing should always be individualised under medical supervision.
For children (off-label), the dosage is typically based on body weight, ranging from 0.5 to 1.5 mg/kg/day depending on the condition and severity.
Take deflazacort with or without food. Swallow the tablet whole.
Follow your healthcare provider’s instructions strictly.
If a dose is missed, take it as soon as you remember. If it’s close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for the missed one.
Informasi Keamanan Penting Penting
PÈNGET: Read this section carefully before taking deflazacort.
Adrenal suppression: Deflazacort, like all corticosteroids, causes suppression of the hypothalamic-pituitary-adrenal (HPA) axis with long-term use.
Do not stop deflazacort abruptly. Doses must be tapered gradually under medical supervision.
Abrupt discontinuation after prolonged use can cause adrenal crisis, a potentially life-threatening condition characterised by severe fatigue, weakness, low blood pressure, nausea, and confusion.
Long-term use of deflazacort increases the risk of:
- Osteoporosis and fractures (particularly vertebral and hip fractures)
- Cataracts and glaucoma (increased intraocular pressure)
- Hyperglycaemia and new-onset diabetes mellitus
- Immunosuppression and increased susceptibility to infections (including opportunistic infections such as Pneumocystis jirovecii pneumonia and strongyloides)
- Cushingoid features (moon face, truncal obesity, buffalo hump, striae, easy bruising)
- Growth retardation in children (monitor growth regularly in paediatric patients)
- Avascular necrosis of bone (particularly the femoral head)
- Psychiatric effects: mood changes, insomnia, psychosis (especially at high doses)
- Peptic ulceration (risk increased when used with NSAIDs)
Paediatric patients on long-term deflazacort for DMD require regular monitoring of growth (height and weight), bone mineral density (DEXA scans), blood glucose levels, ophthalmological examinations (for cataracts and glaucoma), and adrenal function.
Kandhutan: There are no adequate and well-controlled studies of deflazacort in pregnant women. Corticosteroids have been shown to be teratogenic in animal studies.
Deflazacort should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Infants born to mothers who received corticosteroids during pregnancy should be monitored for signs of adrenal insufficiency.
Nyusoni: Corticosteroids are excreted in human milk. Use with caution in breastfeeding women and consider the benefits of breastfeeding alongside the risks.
Vaksin urip: Live-attenuated and live vaccines are contraindicated during immunosuppressive doses of deflazacort.
All immunisations should be administered according to guidelines prior to starting deflazacort. Live vaccines should be given at least 4 to 6 weeks before starting therapy.
Efek sisih Deflazacort
While Deflazacort can be effective, it may also cause side effects.
Efek Sampingan Umum
- Gain bobot
- Tambah napsu
- Owah-owahan swasana ati (contone, kuatir, depresi)
- insomnia
- Tingkat gula getih dhuwur
Serious Side Effects
- Tambah risiko infèksi
- Osteoporosis (penipisan tulang)
- Masalah gastrointestinal (contone, ulkus)
- Masalah mripat (contone, katarak, glaukoma)
- Supresi adrenal (ora bisa ngasilake steroid alami)
Interaksi Narkoba
Deflazacort bisa berinteraksi karo sawetara obat lan zat, kalebu:
- Inhibitor CYP3A4: Strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, and ritonavir) can increase deflazacort levels. If co-administration cannot be avoided, the deflazacort dose should be reduced to one-third of the recommended dose.
- CYP3A4 inducers: Drugs such as rifampicin, carbamazepine, phenytoin, and phenobarbital can reduce deflazacort levels, potentially decreasing its effectiveness.
- Antikoagulan: Kayata warfarin, sing bisa uga duwe efek sing diowahi.
- Obat antidiabetik: Bisa uga mbutuhake pangaturan amarga tingkat gula getih mundhak.
- Nonsteroidal anti-inflammatory drugs (NSAIDs): Tambah risiko pendarahan gastrointestinal.
- Vaksin: Live-attenuated vaccines are contraindicated. Killed or inactivated vaccines may have reduced immunological response during corticosteroid therapy.
Tansah ngandhani panyedhiya kesehatan babagan kabeh obat lan suplemen sing sampeyan gunakake kanggo nyegah interaksi potensial.
Keuntungan saka Deflazacort
Despite the risks associated with long-term corticosteroid use, deflazacort offers several benefits when used appropriately:
- DMD: In Duchenne muscular dystrophy, deflazacort has been shown to prolong ambulation (ability to walk), slow the decline of muscle strength, reduce the risk of scoliosis, and delay the onset of cardiomyopathy and respiratory decline.
- Comparatively bone-sparing: Compared with other corticosteroids such as prednisone, deflazacort has been associated with a lower impact on bone mineral density, making it a preferred choice when long-term corticosteroid therapy is required.
- Anti-inflammatory efficacy: Effective in reducing inflammation and immune-mediated tissue damage in a range of autoimmune and inflammatory conditions.
- Imunosupresi: Useful in managing conditions where suppression of the immune system is required, including organ transplant recipients.
Contraindications saka Deflazacort
Wong tartamtu kudu ngindhari nggunakake Deflazacort, kalebu:
- Wanita meteng: Bisa ngrusak janin. Panganggone kudu dianggep kanthi teliti, lan tes meteng bisa uga dibutuhake sadurunge miwiti perawatan yen meteng bisa.
- Wong sing kena infeksi aktif: Bisa nyuda sistem kekebalan awak, kanthi signifikan nambah risiko nambah utawa nyebarake infeksi.
- Pasien kanthi kondisi kesehatan tartamtu: Kayata penyakit ati sing abot, ulkus peptik aktif, utawa diabetes sing ora bisa dikontrol.
Tansah takon panyedhiya kesehatan kanggo nemtokake yen Deflazacort cocok kanggo kahanan sampeyan.
Ati-ati lan Peringatan
Sadurunge miwiti Deflazacort, nimbang pancegahan ing ngisor iki:
- Monitoring reguler: Pasien mbutuhake tes getih biasa kanggo ngawasi tingkat gula getih, fungsi ati, lan parameter liyane.
- Penghentian bertahap: Yen sampeyan wis ing Deflazacort kanggo wektu lengkap, iku wigati kanggo taper mati pengobatan mboko sithik supaya gejala mundur total.
- Vaksinasi: Rembugan rencana vaksinasi karo panyedhiya kesehatan, utamane babagan vaksin urip.
- Resiko infeksi: Waspada kanggo tandha-tandha infèksi (mriyang, lara tenggorokan, tambah nyeri), lan laporake kanthi cepet menyang dhokter, amarga sistem kekebalan awak bisa ditindhes.
Pitakonan Paling Sering (FAQs)
Apa Deflazacort digunakake?
Deflazacort is FDA-approved for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older. In India, it is also widely used off-label for autoimmune and inflammatory conditions such as rheumatoid arthritis, asthma, nephrotic syndrome, and severe allergic conditions.
What is the correct dose for DMD?
The FDA-approved dose for DMD is 0.9 mg/kg/day, administered once daily. The dose is based on the patient’s body weight and should be calculated by the prescribing physician.
Kepiye cara njupuk Deflazacort?
Biasane dijupuk kanthi lisan ing bentuk tablet utawa diwenehake liwat injeksi, kaya sing diarahake dening panyedhiya kesehatan.
Apa efek samping sing umum?
Efek sisih umum kalebu gain bobot, tambah napsu, owah-owahan swasana ati, lan insomnia.
Can I stop deflazacort suddenly?
No. Deflazacort must not be stopped abruptly after prolonged use. Doses should be tapered gradually under medical supervision to avoid adrenal crisis.
Apa aku bisa njupuk Deflazacort yen meteng?
Deflazacort should be used during pregnancy only if the potential benefit justifies the risk to the foetus. There are no adequate human studies. Discuss with your doctor.
Can I receive vaccines while on deflazacort?
Live vaccines are contraindicated during immunosuppressive doses. Killed or inactivated vaccines may be given but may have a reduced response. All vaccinations should ideally be completed before starting deflazacort.
Is deflazacort the same as prednisolone?
No. While both are corticosteroids, deflazacort is a distinct drug with a different pharmacological profile.
Studies suggest deflazacort may have a comparatively lower impact on bone mineral density and weight gain than prednisone/prednisolone, which is one reason it is preferred for long-term use in DMD.
Kepiye cara kerja Deflazacort?
Iku niru hormon alami kanggo nyuda inflamasi lan nyuda respon imun.
Apa ana efek samping sing serius?
Ya, efek samping sing serius bisa nambah risiko infeksi, osteoporosis, lan masalah gastrointestinal.
Bisa mungkasi njupuk Deflazacort dumadakan?
Ora, penting kanggo nyuda obat kasebut kanthi bertahap ing pengawasan medis kanggo ngindhari gejala mundur.
Apa sing kudu ditindakake yen aku ora kejawab dosis?
Njupuk dosis sing ora kejawab sanalika sampeyan ngelingi, nanging skip yen wis meh wektu kanggo dosis sabanjure. Aja pindho munggah.
Apa Deflazacort bisa sesambungan karo obat liya?
Ya, bisa sesambungan karo antikoagulan, obat antidiabetik, lan NSAID, lan liya-liyane.
Suwene aku bisa njupuk Deflazacort?
Suwene perawatan beda-beda gumantung saka kondisi sing diobati. Tindakake saran saka dhokter kanggo asil sing paling apik.
Does deflazacort affect blood sugar levels?
Yes. Deflazacort can cause hyperglycaemia (elevated blood sugar) and may unmask latent diabetes or worsen existing diabetes.
Blood glucose levels should be monitored regularly, particularly during long-term use.
Should children on deflazacort for DMD be monitored differently?
Yes. Paediatric patients on long-term deflazacort for DMD require regular monitoring of growth, bone mineral density, blood glucose, ophthalmological examinations, and adrenal function.
Your child’s doctor will schedule these assessments.
Jeneng merek
Deflazacort dipasarake ing sawetara jeneng merek, kalebu:
- Emflaza
- Deflazacort
- Deflazacort Sandoz
kesimpulan
Deflazacort is a versatile corticosteroid medication that plays a crucial role in managing various inflammatory and autoimmune conditions.
Sanajan nawakake mupangat sing signifikan, kalebu risiko efek samping tartamtu sing luwih murah dibandhingake karo kortikosteroid liyane, penting kanggo ngerti kabeh efek samping potensial lan interaksi obat.
Tansah konsultasi karo panyedhiya layanan kesehatan sampeyan kanggo nemtokake rencana perawatan sing paling apik sing cocog karo kabutuhan sampeyan, lan njaga komunikasi sing terbuka babagan gejala anyar utawa sing saya parah, utamane sajrone panggunaan jangka panjang utawa nalika nyetel dosis.
Rumah Sakit Paling Apik Cedhak Kula Chennai